WIMM: “First-in-class, oral mutant IDH2 inhibitor reverses differentiation block in Acute Myeloid Leukaemia and produces clinically meaningful responses”, Dr Lynn Quek —

WIMM: “Genetic disorders at the neuromuscular synapse. Can we treat them?”, Prof David Beeson —

Chair: Prof Chris Conlon